You are here: Home » PTI Stories » National » News
Business Standard

MobileODT and Partners to Launch First Wide-Scale Deployment of AI screening for Cervical Cancer

Press Trust of India  |  CHENNAI 

/ -- MobileODT, developer of the Enhanced Visual Assessment (EVA) System, will with and to deliver its FDA-cleared smart mobile colposcope in to perform the first large-scale pilot of (AI) for use in screening. This will give cutting edge, yet low-cost to reach millions of women across who previously had limited access to life saving exams.

432 million women in are at risk of developing cancer, yet only 3.1% receive screening. Lack of equipment, qualified colposcopists, and socioeconomic conditions contribute to low screenings. When testing or a Pap Smear screening does occur, 80% with positive results do not return for treatment resulting in unnecessary loss of life for a highly treatable form of

With AI capabilities, remote collaboration, and improved workflow, the EVA System can provide better access to cervical screening through non-expert analysis at the point of care. The EVA System is currently in use in 29 countries and over 50 US systems.

The clinical study to be conducted at Apollo Hospital Centres throughout India will improve the used in detection by comparing cytologic cotesting to the algorithm performance, using biopsy as ground truth. This represents the first wide-scale validation of the algorithm, screening up to 250 women each day.

Using the EVA System along with the algorithm will greatly improve women's lives across India with on the spot diagnosis and improved patient tracking through the secure digital platform. A previous pilot conducted in six Apollo Hospital Centers to assess the value of the EVA System on improving patient and provider experience found that the EVA System helped early detection of for almost three times as many women compared to those who were identified positive with Pap smear. The study was coordinated by Apollo Research and Innovations (ARI), the research division of Group.


is reimagining medical visualization and to enhance women's health, saving lives by enabling detection.




is one of the largest and solutions providers in India. GenWorks enables to access affordable technologies and enable adoption to improve clinical outcomes.

Genworks contact:

Geetanjali Chowdhury - geetanjali.chowdhury@genworkshealth.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, January 08 2019. 10:35 IST